AIM: To evaluate the noninvasive parameters and hepatic fibrosis scores in obese children with nonalcoholic fatty liver disease (NAFLD). METHODS: A total of 77 children diagnosed with NAFLD via liver biopsy were included and divided into 2 subgroups according to the histopathologic staging of hepatic fibrosis: mild (stage 0-1) vs significant fibrosis (stage 2-4). Clinical and laboratory parameters were evaluated in each patient. The aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, AST/platelet ratio index (APRI), PGA index, Forns index, FIB-4, NAFLD fibrosis score, and pediatric NAFLD fibrosis index (PNFI) were calculated. RESULTS: No clinical or biochemical parameter exhibited a significant difference between patients with mild and significant fibrosis. Among noninvasive hepatic fibrosis scores, only APRI and FIB4 revealed a significant difference between patients with mild and significant fibrosis (APRI: 0.67 ± 0.54 vs 0.78 ± 0.38, P = 0.032 and FIB4: 0.24 ± 0.12 vs 0.31 ± 0.21, P = 0.010). The area under the receiving operating characteristic curve of FIB4 was 0.81, followed by Forns index (0.73), APRI (0.70), NAFLD fibrosis score (0.58), AST/ALT ratio (0.53), PGA score (0.45), and PNFI (0.41). CONCLUSION: APRI and FIB4 might be useful noninvasive hepatic fibrosis scores for predicting hepatic fibrosis in children with NAFLD.
AIM: To evaluate the noninvasive parameters and hepatic fibrosis scores in obesechildren with nonalcoholic fatty liver disease (NAFLD). METHODS: A total of 77 children diagnosed with NAFLD via liver biopsy were included and divided into 2 subgroups according to the histopathologic staging of hepatic fibrosis: mild (stage 0-1) vs significant fibrosis (stage 2-4). Clinical and laboratory parameters were evaluated in each patient. The aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, AST/platelet ratio index (APRI), PGA index, Forns index, FIB-4, NAFLD fibrosis score, and pediatric NAFLD fibrosis index (PNFI) were calculated. RESULTS: No clinical or biochemical parameter exhibited a significant difference between patients with mild and significant fibrosis. Among noninvasive hepatic fibrosis scores, only APRI and FIB4 revealed a significant difference between patients with mild and significant fibrosis (APRI: 0.67 ± 0.54 vs 0.78 ± 0.38, P = 0.032 and FIB4: 0.24 ± 0.12 vs 0.31 ± 0.21, P = 0.010). The area under the receiving operating characteristic curve of FIB4 was 0.81, followed by Forns index (0.73), APRI (0.70), NAFLD fibrosis score (0.58), AST/ALT ratio (0.53), PGA score (0.45), and PNFI (0.41). CONCLUSION: APRI and FIB4 might be useful noninvasive hepatic fibrosis scores for predicting hepatic fibrosis in children with NAFLD.
Authors: C Ricci; R Longo; E Gioulis; M Bosco; P Pollesello; F Masutti; L S Crocè; S Paoletti; B de Bernard; C Tiribelli; L Dalla Palma Journal: J Hepatol Date: 1997-07 Impact factor: 25.083
Authors: Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés Journal: Hepatology Date: 2002-10 Impact factor: 17.425
Authors: J P Teare; D Sherman; S M Greenfield; J Simpson; G Bray; A P Catterall; I M Murray-Lyon; T J Peters; R Williams; R P Thompson Journal: Lancet Date: 1993-10-09 Impact factor: 79.321
Authors: Aurora Loaeza-del-Castillo; Francisco Paz-Pineda; Edgar Oviedo-Cárdenas; Francisco Sánchez-Avila; Florencia Vargas-Vorácková Journal: Ann Hepatol Date: 2008 Oct-Dec Impact factor: 2.400
Authors: Linda Aurpibul; Torsak Bunupuradah; Sam Sophan; David Boettiger; Dewi K Wati; Lam V Nguyen; Vonthanak Saphonn; Rawiwan Hansudewechakul; Kulkanya Chokephaibulkit; Pagakrong Lumbiganon; Khanh H Truong; Viet C Do; Nagalingeswaran Kumarasamy; Nik K N Yusoff; Kamarul Razali; Nia Kurniati; Siew M Fong; Revathy Nallusamy; Annette H Sohn Journal: Pediatr Infect Dis J Date: 2015-06 Impact factor: 2.129
Authors: Juan J Díaz; Kathleen M Gura; Juliamna Roda; Antonio R Perez-Atayde; Christopher Duggan; Tom Jaksic; Clifford W Lo Journal: J Pediatr Gastroenterol Nutr Date: 2013-09 Impact factor: 2.839
Authors: Manish Dhyani; Michael S Gee; Joseph Misdraji; Esther Jacobowitz Israel; Uzma Shah; Anthony E Samir Journal: J Med Imaging Radiat Oncol Date: 2015-10-27 Impact factor: 1.735